DIA
Drug Information Association Logo

Student & Professional Posters

Search Poster Presentation 

Poster Number Poster Title Poster Type Date/Time Poster Presenter
M 01 Evaluation of Cytochrome P450 2C19 Activity in Normal, Healthy Adult Subjects in a Western Indian Population Student Mon, Jun 24 10:00AM Harshavardhan Narendra Sant
M 02 Promoting Medical Technology Innovation: Lessons Learned from the Case of Bare Metal Coronary Stents Student Mon, Jun 24 10:00AM Shuai Xu
M 03 Quality Clinical Trial Monitoring in Nigeria: The Impact of Regulatory Oversight and Resource Capacity Student Mon, Jun 24 10:00AM Elizabeth Olubukola Adeniran
M 04 A Cost Analysis of Skeletal Related Events Among Elderly Men with Stage IV Metastatic (M1) Prostate Cancer Student Mon, Jun 24 10:00AM Jinani Charmila Jayasekera
M 05 Challenges in Discovery and Development of Orphan Drugs and Possible Solutions: Indian Scenario Student Mon, Jun 24 10:00AM Priti Padmakar Pednekar
M 06 Receipt of ACE Inhibitors or ARBs Among Medicare Beneficiaries with Diabetes and Hypertension Student Mon, Jun 24 10:00AM Satya Surbhi
M 07 Comparison of European Drug Approvals to US Student Mon, Jun 24 10:00AM Amy Jia Wang
M 08 Awareness of Komfo Anokye Teaching Hospital (KATH) Clinical Staff of the DOTS Strategy for the Treatment of Tuberculosis Student Mon, Jun 24 10:00AM Peter Yamoah
M 09 The Registration of Biosimilar Medicines: The Case of Low Molecular Weight Heparines in View of the New CHMP Guideline Student Mon, Jun 24 10:00AM Anna Magdalena Perelka
M 10 Does the Essential Medicines Policy Succeed in China? Empirical Study on Rational Medicine Use in Primary Health Institutions Student Mon, Jun 24 10:00AM Shi Yin
M 11 Disparities in Influenza Vaccinations Among Community Pharmacy Patients and Non-Community Pharmacy Respondents Student Mon, Jun 24 10:00AM Kiraat Munshi
M 12 Assessment of Severity Grading Differences Between Terms in Common Toxicity Criteria Used in Clinical Trials Student Mon, Jun 24 10:00AM Luke Baertlein
M 13 Update of Current Compliance With Required Reporting of Summary Results on ClinicalTrials.gov Student Mon, Jun 24 10:00AM Mollie Reidland
M 14 Communicating the Benefits and Risk of Medicines to Patients: The Pharmacy Student’s Point of View Student Mon, Jun 24 10:00AM Andrew Aidan Brown
M 15 Technological Innovations in Medication Packaging to Improve Patient Adherence: A Systematic Review Student Mon, Jun 24 10:00AM Kyle Douglas Checchi
M 16 Drug Disposal: Addressing Current Drug Disposal Practices and Pharmacovigilance Student Mon, Jun 24 10:00AM Hye J. Kim
M 17 Antimicrobial Susceptibility Trends of Urinary Tract Infections: A 10-year Regional Antibiogram of ESKAPE Pathogens Student Mon, Jun 24 10:00AM Ajinkya M. Pawar
M 18 Awareness and Use of Video Games for Rehabilitation and Therapy in Indian Healthcare Centers Student Mon, Jun 24 10:00AM Priya Jayant Karambelkar
M 19 Current Challenges of Regulatory Systems in Low and Middle-Income Countries Student Mon, Jun 24 10:00AM Saleh Bessissow
M 20 Research of the Non-therapeutic Impact Factors Correlation in Clinical Parameters Estimation During Clinical Trials Student Mon, Jun 24 10:00AM Kseniia Ratushna
T 01 Toward a New Regulatory Paradigm for Lipid Emulsions for Parenteral Nutrition Professional Tue, Jun 25 11:45AM Edward Tabor
T 02 Recruitment Metrics From Together RA: A Study in Rheumatoid Arthritis Patients to Evaluate Feasibility of Direct-to-Patient Research Approach Professional Tue, Jun 25 11:45AM Elisa F. Cascade
T 03 Site-level Quality Assurance Outcome: Identification of Sponsor-provided Source Documents With Greatest Prevalence of Errors Professional Tue, Jun 25 11:45AM Patrick G. Clay
T 04 Potential Differences in Subjects From Physician Recruitment Versus Centralized Recruitment Campaigns in a Clinical Trial Professional Tue, Jun 25 11:45AM Raymond Panas
T 05 Global Clinical Trials: Challenges, Risks and Rewards Professional Tue, Jun 25 11:45AM Ai Li
T 06 A Comparison of the Statistical Properties of Confidence Intervals for the Difference in Two Proportions Professional Tue, Jun 25 11:45AM Michael C. Mosier
T 07 Comparing the Sensitivity of Safety Signal Identification When Using Three Methods: EBGM, U-Chart and Increased Frequency Professional Tue, Jun 25 11:45AM Wendy Ye
T 08 Develop a Project Management Training Program for Clinical Trials Sites to Manage Complex Clinical Trials Effectively Professional Tue, Jun 25 11:45AM Kay Friel
T 09 Different Competencies and Skill Sets for Regulatory Medical Writers and Publication Writers Professional Tue, Jun 25 11:45AM Thomas Martin Schindler
T 10 Risk-based Centralized Monitoring of Clinical Trials: A Statistical Approach Professional Tue, Jun 25 11:45AM Peng Yang
T 11 Failed Trials and Protocol Design: Is There a Relationship? Professional Tue, Jun 25 11:45AM Patricia Brown
T 12 The Evolving Oncology Clinical Trial Landscape in Asia: 10 Year Trend Professional Tue, Jun 25 11:45AM Anish Kaustubh Sule
T 13 Anxiolytic-like Effect of Beta Receptor Agonist Amibegron May be Related to Interaction of Serotonin Receptor Subtypes Professional Tue, Jun 25 11:45AM Pelin Tanyeri
T 14 What Are the Attributes That Companies Believe Would Help Agencies to Make Quality Regulatory Review Decisions? Professional Tue, Jun 25 11:45AM Lawrence Liberti
T 15 Quality Systems for Contract Clinical Supply Operations: Using Risk Analysis to Meet Global Requirements Professional Tue, Jun 25 11:45AM Sarah Wartman
T 16 So You Have a CTMS, Now What? Using Technology to Optimize Clinical Operational Processes - the DAIDS RSC Experience Professional Tue, Jun 25 11:45AM Idongesit Essiet-Gibson
T 17 Measuring Outcomes in Phase 1 Clinical Trials Professional Tue, Jun 25 11:45AM Mary Gaylord
T 18 Advantages and Mass Balance Results Dosing [14C]-Oncology Drugs to Normal Healthy Volunteers: Compiled Data from 22 AME Studies Professional Tue, Jun 25 11:45AM Robert George Kochan
T 19 Impact of Public Comments on Prescription Drug Benefits in Essential Health Benefits Final Ruling Professional Tue, Jun 25 11:45AM Justin Balint
T 20 With the Changing Life Sciences and Regulatory Landscapes: Evolutions in Drug Safety and Pharmacovigilance Operating Models Professional Tue, Jun 25 11:45AM Glenn Carroll
T 21 New Survey Data Results: Patient Preferences for Reminders in Clinical Trials With Patient Diaries Professional Tue, Jun 25 11:45AM Jack Edler
T 22 Developing Site Monitoring Triggers to Support Risk-based Monitoring Professional Tue, Jun 25 11:45AM DeAnn S. Hyder
T 23 The Use of Compliant Text Messaging to Increase Patient Engagement in a Study Comparing Oral Contraceptive Symptoms Professional Tue, Jun 25 11:45AM Chris Watson
T 24 Monitoring without SDV or Regulatory Document Collection: The Monitor's Critical Role and How it Has Changed Professional Tue, Jun 25 11:45AM Christine Riley-Wagenmann
T 25 Advancing Patient Registry Methodology with an Outcome Measures Framework Professional Tue, Jun 25 11:45AM Jannette Karl
T 26 Spontaneous Ventricular Arrhythmias in Early Clinical Trials: a Report from a Single and Repeated Ascending Dose Study Professional Tue, Jun 25 11:45AM Antonio Ferrari
T 27 Gamification in the Pharmaceutical Industry: An Innovative Approach to Education and Awareness Among Patients and Health Care Professional Tue, Jun 25 11:45AM Boas Nahm
T 28 Characterization of Renal Biomarkers for Use in Drug Development: Biomarker Evaluation in “Healthy Volunteers” Professional Tue, Jun 25 11:45AM Stephen Furlong
T 29 Asian Investigators Enrollment Prediction: An Assessment of Accuracy Against Actual Performance Professional Tue, Jun 25 11:45AM Elvira Zenaida Plata Lansang
T 30 Embracing Social Media and what it means for maintaining Compliance Professional Tue, Jun 25 11:45AM Kelly Lyn Traverso
T 31 Return on Innovation Investment for Life Science Technologies Professional Tue, Jun 25 11:45AM Andy MacKelfresh
T 32 Comparative Safety of Second-Generation Antipsychotics and Risk of Pneumonia Professional Tue, Jun 25 11:45AM Sandhya Mehta
T 33 Consequences of Non-compliance to Osteoporosis Medication Among Osteoporotic Women Professional Tue, Jun 25 11:45AM Ankita Modi
T 34 FDA Trends: Is Your Company Ready for the Next Inspection? Professional Tue, Jun 25 11:45AM Diana Ye
W 01 Inspections: Streamlining Backstage Operations Using the Cloud Professional Wed, Jun 26 11:45AM Suvarna Lakshmi Jetti
W 02 Highly-Automated Analysis of QTcI/QTcF in Thorough QT (TQT) Study Professional Wed, Jun 26 11:45AM Pierre Maison-Blanche
W 03 Determinants for Predicting Serious Adverse Event (SAE) Rates Across Study Duration in Selected CNS Indications Professional Wed, Jun 26 11:45AM Dena Cosgrove
W 04 Remote Informed Consent Review: Results of Implementation in Phase III Trial Professional Wed, Jun 26 11:45AM Penelope K. Manasco
W 05 Characteristics of a US Rheumatoid Arthritis Cohort: Baseline Data from CORRONA Professional Wed, Jun 26 11:45AM Katherine Saunders
W 06 A Trio of Talent: Scientific Collaboration Inside a CRO Professional Wed, Jun 26 11:45AM Margaret S. Richards
W 07 Labeling for Devices: A Global Solution Professional Wed, Jun 26 11:45AM Eileen S. Kahn
W 08 Microdose Study on Three Aromatase Inhibitors Professional Wed, Jun 26 11:45AM Toshiyoshi Tominaga
W 09 Current Scenario of Clinical Research Sites in Thailand: A Ground Up Approach to Clinical Site Selection in Emerging Countries Professional Wed, Jun 26 11:45AM Lisa Maire Saldanha
W 10 Evaluation of Pain Drugs: Role of Undetected Underlying Sleep Pathologies Professional Wed, Jun 26 11:45AM Barry Peterson
W 11 Selective Blockade of RyRIII May Present a Protective Effect against Neuronal Insult in Cell Model Professional Wed, Jun 26 11:45AM Jin Zhang
W 12 Development of Guidance for Handling Adverse Drug Reaction Reports at National Level Professional Wed, Jun 26 11:45AM So Hyeon Ahn
W 14 Randomized Placebo-Control Trial of Arginine Therapy for Treatment of Children with Sickle Cell Disease and Vasoocclusive Pain Professional Wed, Jun 26 11:45AM Claudia R. Morris
W 15 Best Practices for Optimizing Global Biospecimen Collections for Prospective and Retrospective Clinical Research Professional Wed, Jun 26 11:45AM Kristina Robson
W 16 Comparison of the US Package Insert and the EU Summary of Product Characteristics Professional Wed, Jun 26 11:45AM Jay K. Bordoloi
W 17 Genotoxic Evaluation of a Chloroalcohol Resulting From Acid Degradation of an Oral Pharmaceutical Containing an Oxetane Ring Professional Wed, Jun 26 11:45AM Andrew J. Dropsey
W 18 Recruitment Metrics From a Direct-to-patient Approach to Enroll Patients in a Diabetes Practice-based Research Network Professional Wed, Jun 26 11:45AM John Reites
W 19 Development of a Quality Program for Clinical Research Sites of Brazilian Clinical Research Cancer Network Professional Wed, Jun 26 11:45AM Debora Cristina Victorino Azevedo
W 20 The Role of Product Identification Systems in Pharmacovigilance (PV) for Biologics in the Biosimilars Era Professional Wed, Jun 26 11:45AM Thomas Felix
W 21 Please Pass the New Template: Enhancement of Postauthorization Safety Study Protocol Templates Aligned With Guidelines Professional Wed, Jun 26 11:45AM Diane Carpentier
W 22 What Medical Writers Contribute and What They Need to Know Professional Wed, Jun 26 11:45AM Barbara J. Stephenson
W 23 Preventing Shortages of Biologic Medicines Professional Wed, Jun 26 11:45AM Sundar Ramanan
W 24 A Prospective Clinical Trial of a Scoliosis Growth Modulation Clip/Screw Device: Initial Safety Results Professional Wed, Jun 26 11:45AM Joseph Reynolds
W 25 Comparative Risks of Organ Dysfunction Associated with Individual Antiepileptic Drugs Following FDA Black Box Warning Professional Wed, Jun 26 11:45AM Alexis Parente
W 26 Registry of Patient Registries (RoPR): Supporting Registries for Comparative Effectiveness Research Professional Wed, Jun 26 11:45AM Thomas Taylor
W 27 A Self-service Approach to Reporting Using Dimensional Data Warehouse Architecture Professional Wed, Jun 26 11:45AM Arvind Nagaraj
W 28 Burden of Post-treatment Fractures in Terms of Health Care Cost and Utilization Among Patients on Osteoporosis Treatment Professional Wed, Jun 26 11:45AM Arun Krishna
W 29 The Impact of Tyrosine Kinase Inhibitors on Stage IV Distant Renal Cell Carcinoma Overall Survival Professional Wed, Jun 26 11:45AM Ashley R. Brower
W 30 Factors Affecting Strategies in Asthma and COPD Clinical Trials Professional Wed, Jun 26 11:45AM Vikki Brandi
W 31 Application of Clinical Drug Trial Methodology to the Evaluation of Nutraceuticals Professional Wed, Jun 26 11:45AM Gary Kay
W 32 Regulatory Systems Assessments in Selected Low-and Middle-income Countries (LMICs) Professional Wed, Jun 26 11:45AM Hye Lynn Choi
© 2015 DIA